Importantly, although several AMPs have been tested in vitro, in CF lung sputum, or in vivo, in animal models of chronic infections [41], no studies have been carried out to evaluate the antimicrobial/antipseudomonal efficacy of AMPs in models that better reflect the CF lung environment characterized by mucus plugging and chronic neutrophils inflammation. Here, ADSL is linked to cystic fibrosis.